1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare TumoursAdvanced Rare TumoursActive, not recruitingPhase 22026-08-11NCT01396408